ReviewAntibiotics (Basel, Switzerland)2021
Oral Antibiotic for Empirical Management of Acute Dentoalveolar Infections-A Systematic Review.
Review in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 39 citations in OpenAlex.
- Patterns of Surgical Prophylaxis Prescribing for Dentoalveolar Procedures in Australian Hospitals: 2016-2022.Australian dental journal · 2026Article
- Dental Antibiotic Prescribing Practices and Antimicrobial Resistance Knowledge in Singapore.International dental journal · 2026Article
- Quality and reliability Of YouTube videos on maxillofacial infections: a cross-sectional study.BMC oral health · 2026Article
- Bacterial Profile and Antibiotic Resistance in Oral and Maxillofacial Infections.Journal of clinical medicine · 2026Article
- Article
- Clinical impact of antibiotic resistance in odontogenic infections: a 12-year analysis of 740 cases.Clinical oral investigations · 2025Article
- Optimal Duration of Antibiotic Therapy for Space Infections in the Maxillofacial Region: A Systematic Review.Craniomaxillofacial trauma & reconstruction · 2025Review
- Palatal Abscess of Endodontic Origin with Extensive Radiolucency in Maxillary CBCT Imaging.Diagnostics (Basel, Switzerland) · 2025Article
- Factors influencing recurrence after in-hospital treatment of odontogenic-related oromaxillofacial infections: a single-centre experience.BMC oral health · 2025Article
- The role of dental status in the pathogenesis and severity of peritonsillar and cervical infections.Frontiers in medicine · 2025Article
- Epidemiology and Management Paradigm of Head and Neck Infections, Including COVID-19 Pandemic Period: A 10-Year Retrospective Study in a Maxillofacial Center of Cluj-Napoca.Journal of clinical medicine · 2024Article
- Changes in Medication Prescribing Due to COVID-19 in Dental Practice in Croatia-National Study.Antibiotics (Basel, Switzerland) · 2023Article
- Sonication versus the conventional method for evaluation of the dental microbiome: a prospective pilot study.BMC oral health · 2022Article
- Indications for the use of metronidazole in the treatment of non-periodontal dental infections: a systematic review.JAC-antimicrobial resistance · 2022Review
- Antimicrobial resistance of bacterial pathogens isolated from the infections of post maxillofacial surgery.Journal of medicine and life · 2022Article
- Microbiota of Dental Abscess and their Susceptibility to Empirical Antibiotic Therapy.Contemporary clinical dentistryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
Concerns regarding increasing antibiotic resistance raise the question of the most appropriate oral antibiotic for empirical therapy in dentistry. The aim of this systematic review was to investigate the antibiotic choices and regimens used to manage acute dentoalveolar infections and their clinical outcomes. A systematic review was undertaken across three databases. Two authors independently screened and quality-assessed the included studies and extracted the antibiotic regimens used and the clinical outcomes. Searches identified 2994 studies, and after screening and quality assessment, 8 studies were included. In addition to incision and drainage, the antibiotics used to manage dentoalveolar infections included amoxicillin, amoxicillin/clavulanic acid, cefalexin, clindamycin, erythromycin, metronidazole, moxifloxacin, ornidazole and phenoxymethylpenicillin. Regimens varied in dose, frequency and duration. The vast majority of regimens showed clinical success. One study showed that patients who did not receive any antibiotics had the same clinical outcomes as patients who received broad-spectrum antibiotics. The ideal choice, regimen and spectrum of empirical oral antibiotics as adjunctive management of acute dentoalveolar infections are unclear. Given that all regimens showed clinical success, broad-spectrum antibiotics as first-line empirical therapy are unnecessary. Narrow-spectrum agents appear to be as effective in an otherwise healthy individual. This review highlights the effectiveness of dental treatment to address the source of infection as being the primary factor in the successful management of dentoalveolar abscesses. Furthermore, the role of antibiotics is questioned in primary space odontogenic infections, if drainage can be established.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.